Oncomethylome Sciences Inc is categorized under Medical Research in Durham, NC and active since 2003.
Oncomethylome Sciences Inc was established in 2003, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Herman Spolders at the company’s single location by writing to 2505 Meridian Parkway, Durham, North Carolina NC 27713 or by phoning (919) 281-0980. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Oncomethylome Sciences Inc |
| Contact Person: | Herman Spolders |
| Address: | 2505 Meridian Parkway, Durham, North Carolina 27713 |
| Phone Number: | (919) 281-0980 |
| Website Address: | mdxhealth.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Oncomethylome Sciences Inc was started in 2003 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Herman Spolders for inquiries that concern Oncomethylome Sciences Inc by calling the company number (919) 281-0980, as your correspondence is most welcome. Additionally, the physical location of the single location of Oncomethylome Sciences Inc can be found at the coordinates 35.910468,-78.893225 as well as the street address 2505 Meridian Parkway in Durham, North Carolina 27713.
For its online presence, you may visit Oncomethylome Sciences Inc’s website at mdxhealth.com and engage with its social media outlets through on Twitter and on Facebook.